“… ( Jafarinejad-Farsangi et al, 2020 ) | miR-24 | In vivo | Patients hospitalized for COVID-19 | 369 plasma | | | EC-EV miR-24 is associated with cerebrovascular complications in COVID-19. | ( Gambardella et al, 2021a ) |
hsa-miR-190a | In vivo | | 50 | | | hsa-let-7d, hsa-miR-17, hsa-miR-34b, hsa-miR-93, hsa-miR-200b, hsa-miR-200c, hsa-miR-223 expression levels were decreased and hsa-miR-190a and hsa-miR-203 increased in COVID-19 patients. | ( Demiray et al, 2021 ) |
hsa-miR-340-3p, hsa-miR-652-3p, hsa-miR-4772-5p, hsa-miR-192-5p, and hsa-miR-1291 | Bioinformatics | | | | Autophagy | These miRNAs may be markers to forecast alterations in mild SARS-CoV-2 infection. |
…”